LuMind RDS Foundation Awards More Than $1.6 Million in New Grants for Cognition Research for Individuals with Down Syndrome

Categories: Ds Research, News
Person with Down syndrome celebrates
LuMind™ Research Down Syndrome Foundation (LuMind RDS) — formerly the Down Syndrome and Treatment Foundation and Research Down Syndrome — advances Down syndrome (Ds) cognition and Alzheimer’s disease (AD) research with $1,615,000 in funding awards for seven new research grants in 2017. Since 2004, LuMind RDS has raised more than $15 million and funded research …

Read More

Meet our San Francisco Runners

Categories: Blog, Meet Our Friends, News, Runners Program
We’re so excited to cheer on our runners participating in the San Francisco Marathon, Half Marathon, and 5k races this weekend! Please join us in supporting Megan Mozart, Leyda Simon, Reyna and Eduwin Rodriguez as they take on a hilly 26.2 miles Sunday morning. Megan began running with LuMind RDS Runners four years ago after …

Read More

Money = Time: Ice Bucket Challenge Leads to ALS Gene Discovery

Categories: Blog, News, Why Support Research?
We just kicked off our Summer Fundraising Appeal with the theme Money = Time. We’ve all heard the saying Time is Money, but in research money leads to an accelerated pace of discoveries, shortening the time to breakthroughs. Just as we kicked off our campaign there was a report from the world of ALS research …

Read More

NDSC Wrap Up

Categories: Blog, Meet Our Friends, News, Runners Program
We loved seeing so many familiar faces and making new friends at the National Down Syndrome Congress Convention in Orlando, Florida. We’ve gathered some pictures below – enjoy! Big thanks to the Helferich family, especially Lucas, who worked hard to promote the Runners program at our table. Thank you! On Saturday morning Dr. Michael Harpold, Chief Scientific …

Read More

Statement from LuMind Research Down Syndrome Foundation on the Roche Clinical Trials

Categories: Blog, Clinical Trials, Ds Research, News
From LuMind RDS Board Chairman, Ryan Hartman We thank you for turning to LuMind Research Down Syndrome with your questions and comments about the news of the Roche CLEMATIS Phase 2 clinical trial for RG1662/Basmisanil. As the largest source of private funding for Down syndrome cognition research, we are in contact with many people from our …

Read More